{
    "success": true,
    "data": {
        "leverage": true,
        "derivates": true,
        "swaps": true,
        "inverse": true,
        "replication_method": "synthethic",
        "ucits": true,
        "type": "ETF",
        "complex_factors": [
            "Inverse index tracking with daily rebalancing and -2x leverage",
            "Use of over-the-counter total return swaps (derivatives) for replication",
            "Complex structure affecting investor understanding of risks (counterparty risk, collateral risk)"
        ],
        "classification": "complex",
        "supporting_data": "The Amundi EURO STOXX 50 Daily (-2x) Inverse UCITS ETF uses a daily rebalancing strategy with -2x leverage to gain inverse exposure to the EURO STOXX 50 index. This strategy, central to the ETF's objective, requires the use of over-the-counter total return swaps, which are derivative instruments. The use of swaps introduces counterparty risk (the risk of the swap counterparty defaulting), collateral risk (the risk of insufficient collateral), and introduces a degree of opacity as the ETF's underlying holdings don't directly reflect the inverse index. The daily rebalancing with leverage creates a complex risk profile with potential for performance not matching a simple inverse relationship over time, and the fund has acknowledged a possibility of the fundu2019s performance tracking in the same direction as the parent index, rather than in the inverse direction, over periods longer than a single day. These are factors that make the product complex for retail investors to understand, and the product itself is explicitly designed to deliver a higher risk profile than typical passive strategies which tend to track directly. The Key Investor Information Document (KID) confirms the product is a UCITS and thus subject to certain regulatory protections; however, the sophisticated structure and use of derivatives to achieve a negative two times leveraged inverse index replication make it complex under MiFID II. The KID also acknowledges that the product may not be suitable for investors with short-term investment horizons, due to the complex nature of the strategy."
    }
}